| Literature DB >> 27579148 |
Jan Nevoral1, Jean-Francois Bodart2, Jaroslav Petr3.
Abstract
Creation of both gametes, sperm and oocyte, and their fusion during fertilization are essential step for beginning of life. Although molecular mechanisms regulating gametogenesis, fertilization, and early embryonic development are still subjected to intensive study, a lot of phenomena remain unclear. Based on our best knowledge and own results, we consider gasotransmitters to be essential for various signalisation in oocytes and embryos. In accordance with nitric oxide (NO) and hydrogen sulfide (H2S) physiological necessity, their involvement during oocyte maturation and regulative role in fertilization followed by embryonic development have been described. During these processes, NO- and H2S-derived posttranslational modifications represent the main mode of their regulative effect. While NO represent the most understood gasotransmitter and H2S is still intensively studied gasotransmitter, appreciation of carbon monoxide (CO) role in reproduction is still missing. Overall understanding of gasotransmitters including their interaction is promising for reproductive medicine and assisted reproductive technologies (ART), because these approaches contend with failure of in vitro assisted reproduction.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27579148 PMCID: PMC4992752 DOI: 10.1155/2016/1730750
Source DB: PubMed Journal: Oxid Med Cell Longev ISSN: 1942-0994 Impact factor: 6.543
Figure 1Gasotransmission in oocytes, resulting in S-sulfhydration and nitrosylation of various factors. Both gasotransmitters NO and H2S are enzymatically released, respectively, from L-arginine and L-cysteine. Subsequently, NO- and/or H2S-posttranslationally modified proteins lead to MPF/MAPK-orchestrated meiotic maturation reinitiation (equal to GVBD, germinal vesicle breakdown) and completion (with extruded polar body and small particles visible in perivitelline space). S-sulfhydration of MEK, upstream MAPK kinase, is known [61] and more S-sulfhydrated factors are considered. In addition to S-sulfhydration, S-nitrosylation seems to be exclusive mechanism of NO-regulated oocyte maturation [34]. Disclosure of complete “S-sulfhydration” and “S-nitrosylation” is still lacking (X-S-SH, X-S-NO) and we can assume wide protein index underwent this posttranslational modifications as well as NO-H2S intraprotein cross-talking (HS-S-X-S-NO).
Figure 2NO action in oocyte activation is evolutionary inconsistent. The NO/sCG/cGMP/PKG signal pathways are presumed, where dual NO effect on sCG, resulting in its S-nitrosylation and NO binding, is expectable. Obviously, dependency of fertilization and oocyte activation, followed by cleavage and the second polar bod extrusion, is shaded in evolutionary more developed organisms, where fulfilment of certain conditions (Ca2+ presence, pulsative character of NO) is necessary.
Examples of S-nitrosylated and/or S-sulfhydrated proteins.
| Protein | Sulfhydration site | Sulfhydration effect on function | Nitrosylation site | Nitrosylation effect on function | References |
|---|---|---|---|---|---|
| MKP1 | n.d. | n.d. | C258 | Stability of protein | Guan et al., 2012 [ |
|
| |||||
| ERK1 | n.d. | n.d. | C183 (potential) | Prevention of phosphorylation | Feng et al., 2013 [ |
|
| |||||
| CDK2 | n.d. | n.d. | n.d. | Increase of kinase activity | Kumar et al., 2010 [ |
|
| |||||
| CDK5 | n.d. | n.d. | n.d. | n.d. | Foster et al., 2009 [ |
|
| |||||
| CDC25 | n.d. | n.d. | n.d. | Loss of phosphatase activity | Foster et al., 2009 [ |
|
| |||||
| MMP9 | n.d. | n.d. | n.d. | Increase of activity | Harris et al., 2008 [ |
|
| |||||
| PTP1B | C215 | Reduction of phosphatase activity | n.d. | n.d. | Krishnan et al., 2011 [ |
|
| |||||
| PTEN | C71, C124 | Maintenance of enzyme activity and prevention of further oxidation by NO | C83 | Promotion of survival signal and protein degradation | Kwak et al., 2010 [ |
|
| |||||
| Actin | n.d. | Increase of polymerization activity | Cys 374 | Decrease in polymerization activity and network formation | Dalle-Donne et al., 2000 [ |
|
| |||||
| MEK1 | C341 | Facilitation of Parp activation | n.d. | Loss of kinase activity | Ben-Lulu et al., 2014 [ |
|
| |||||
| Parkin | n.d. | Increase of activity | n.d. | Decrease of activity | Chung et al., 2004 [ |
|
| |||||
| GAPDH | C150 | Increase of the activity sevenfold | C150 | Inhibition of glycolytic activity | Greco et al., 2006 [ |